LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features-Reference-Cited by-同舟云学术

LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features

Published:2020-01-31 Issue:5 Volume:30 Page:2861-2870
ISSN:0938-7994
Container-title:European Radiology
language:en
Short-container-title:Eur Radiol

Author:

Kim Se Woo,Joo Ijin^ORCID,Kim Hyo-Cheol,Ahn Su Joa,Kang Hyo-Jin,Jeon Sun Kyung,Lee Jeong Min

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00330-019-06623-9.pdf

Reference33 articles.

1. Korean Liver Cancer Study Group (KLCSG); National Cancer Center, Korea (NCC) (2015) 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 16:465–522

2. Heimbach JK, Kulik LM, Finn RS et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358–380

3. Yu SJ (2016) A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016. Clin Mol Hepatol 22:7

4. Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022

5. Chen R, Gan Y, Ge N et al (2016) Transarterial chemoembolization versus radiofrequency ablation for recurrent hepatocellular carcinoma after resection within Barcelona Clinic liver cancer stage 0/a: a retrospective comparative study. J Vasc Interv Radiol 27:1829–1836

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deep learning-based arterial subtraction images improve the detection of LR-TR algorithm for viable HCC on extracellular agents-enhanced MRI;Abdominal Radiology;2024-04-20

2. LI-RADS version 2018 treatment response algorithm on extracellular contrast-enhanced MRI in patients treated with transarterial chemoembolization for hepatocellular carcinoma: diagnostic performance and the added value of ancillary features;Abdominal Radiology;2024-04-11

3. Reassessment After Locoregional Treatment of Hepatocellular Carcinoma Previous Liver Transplantation: Is MRI Necessary for All Patients?;Transplantation Proceedings;2023-12

4. Value of CT and MR Imaging in Assessment of Loco-regional Ablated Hepatocellular Carcinoma using LI-RADS Treatment Response Algorithm (version 2018);Current Cancer Therapy Reviews;2023-08

5. Updates on LI‐RADS Treatment Response Criteria for Hepatocellular Carcinoma: Focusing on MRI;Journal of Magnetic Resonance Imaging;2023-03-05